期刊文献+

护心方对冠心病合并糖代谢异常患者TLR4炎症通路和中医血瘀证评分的影响 被引量:6

Effect of Huxin Formula on TLR4 Inflammatory Pathway and Blood Stasis Score of Patients with Coronary Heart Disease and Impaired Glucose Metabolism
下载PDF
导出
摘要 目的:同步研究护心方对冠心病合并糖代谢异常患者Toll样受体4信号转导通路及中医血瘀证的影响,探讨以TLR4炎症通路为靶点护心方的干预机制,及炎症反应与血瘀证候的相关性。方法:选择60例冠心病合并糖代谢异常患者,随机分为对照组和治疗组。对照组按常规治疗,治疗组在常规治疗基础上加用护心方,总疗程为60 d。运用Realtime PCR法分别测定治疗前、治疗30 d、60 d外周血单核细胞TLR4 mRNA;ELISA检测外周血血清中C反应蛋白的表达水平。结果:护心方治疗组能在西医常规治疗的基础上更进一步减少了TLR4 mRNA的表达(P<0.05),其抑制炎症的效果与TLR4通路下游指标CRP基本一致。经过中医药治疗,冠心病合并糖代谢异常患者的中医血瘀证评分逐渐降低,至60 d时显示出统计学意义(P<0.05),与TLR4、CRP的表达呈正相关。结论:护心方能显著改善冠心病合并糖代谢异常患者的血瘀证候,而抑制外周血单核细胞To ll样受体4转导通路的激活,减少炎症反应,可能是其重要机制之一,中医的血瘀证候与炎症反应其本质有一定内在联系。 Objective:To observe the effect of Huxin Formula on expression of TLR4 inflammatory pathway and blood stasis score of TCM of patients with coronary heart disease and impaired glucose metabolism in order to study the mechanism of Huxin Formula in the treatment and explore the correlation between inflammation and blood stasis syndrome.Methods: Sixty patients with coronary heart disease and impaired glucose metabolism were randomly divided into two groups. Half patients(n = 30) were treated with Huxin Formula combined with conventional therapy and another 30 patients with conventional therapy alone(control). The mRNA expression level of TLR4 in the peripheral blood and expression of serum C reactive protein were detected by ELISA in two groups and were compared at prior treatment and 30 and60 days after the treatment. Results:The results showed that under the effects of Huxin Formula on patients with coronary heart disease and impaired glucose metabolism,mRNA expression level of TLR4 was decreased significantly after Huxin Formula treatment,which was consistent with CRP trends. There were significant differences between two groups( P〈0. 05). Blood stasis syndrome score of patients decreased to 60 days and showed statistically significant(P〈0. 05). The expressions of TLR4 and CRP were positively correlated. Conclusion: Huxin Formula can significantly restrain the activation of TLR4 signal transduction pathway and reduce inflammatory reaction of patients with coronary heart disease and impaired glucose metabolism. This may be one of the molecular mechanisms of Huxin Formula in the improvement the patient's blood stasis syndrome. To some extent,blood stasis syndrome of TCM and inflammation in essence has some contact.
出处 《中华中医药学刊》 CAS 2014年第10期2475-2477,共3页 Chinese Archives of Traditional Chinese Medicine
基金 广东省中医药管理局中医药强省项目(20121183)
关键词 护心方 冠心病 糖代谢异常 TOLL样受体4 中医药疗法 Huxin Formula coronary heart disease impaired glucose metabolism TLR4 TCM therapy
  • 相关文献

参考文献7

  • 1Bartnik M,Ryden L,Ferrari R,et al.The Prevalence of abnormal glucose regulation patients with acute coronary artery disease across Europeahe Euro Heart Survey diabetes and the heart[J].Eur Heart J,2004,25:1880-1890.
  • 2中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 3Stern MP.The Diabetes and cardiovascular disease.The common soil"hypothesis[J].Diabetes,1995,44(4):369-374.
  • 4Pasterkamp G,Van Keulen JK,De Kleijn DP.Role of Toll-like receptor 4 inthe initiation and progression of atherosclerotic disease[J].Eur J Clin InvesL,2004,34(5):328-334.
  • 5SongMJ,Kim KH,Yoon JM,et al.Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes[J].Biochem Biophys Res Commun,2006,346(3):739-745.
  • 6Zhang HM,Chen LL,Wang L,et al.Macrophage infiltrates with high levels of Toll-like receptor4 expression in white adipose tissues of male Chinese[J].Nutr Metab Cardiovasc Dis,2009,19(10):736-743.
  • 7Adam E,Mullick Peter S,Tobias Linda K,et al.Toll-like receptors and atherosclerosis[J].Immun Res,2006,34(3):193-209.

二级参考文献13

  • 1李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量:13
  • 2King H,Aubert RE,Herman WH.Global burden of diabetes 1995-2025.Prevalence,numerical estimates and projections.Diabetes Care,1998,21:1414-1431.
  • 3Bartnik M,Malmberg K,Hamsten A,et al.Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.J Int Med,2004,256:288-297.
  • 4Coutinho M,Gerstein HC,Wang Y,et al.The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4years.Diabetes Care,1999,22:233-240.
  • 5The DECODE study group on behalf of the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality.Arch Int Med,2001,161:397-404.
  • 6Bartnik M,Malmberg K,Norhammar A,et al.Newly detected abnormal glucose tolerance:an important predictor of long-term outcome after myocardial infarction.Eur Heart J,2004,25:1990-1997.
  • 7Norhammar A,Tenerz A,Nilsson G,et al.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:a prospective study.Lancet,2002,359:2140-2144.
  • 8Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe:the Euro Heart Survey on diabetes and the heart.Eur Heart J,2004,25:1880-1890.
  • 9Hashimoto K,Ikewaki K,Yagi H,et al.Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes.Diabetes Care,2005,28:1182-1186.
  • 10Choi KM,Lee KW,Kim SG,et al.Inflammation,insulin resistance,and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus.J Clin Endocrinol Metab,2005,90:175 -180.

共引文献469

同被引文献86

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部